Our Team

Our team is uniquely positioned to execute our mission of translating our deep understanding of cellular metabolism into medicines that improve the lives of patients with limited or inadequate treatment options.

Alvin Shih
Chief Executive Officer and Board Chair
Arash Yavari
Chief Medical/Scientific Officer
Komal Joshi
Chief Financial Officer
Sarb Shergill
Senior Vice President, Clinical Development
Karen Jauregui
Senior Vice President, Regulatory Affairs, Quality and CMC
Vanessa Murray
Senior Director, Clinical Operations
Marcus Hansen
Senior Director, CMC

You Are About to Leave Imbria Pharmaceuticals

The appearance of external hyperlinks does not constitute endorsement by Imbria Pharmaceuticals of the linked websites, or the information, products or services contained therein.

URL: